B1 - “Hammock healthcare”: The future of pharmacy?

Auditorium 2

Organised by the FIP Industrial Pharmacy Section in collaboration with FIP’s Community Pharmacy Section & Hospital Pharmacy Section

Chairs

Claudia Rijcken, Pharmi, Netherlands and Jaime Acosta Gómez, Farmacia Acosta, Spain

Introduction

We are living in the midst of what is called the fourth revolution. This era is characterized by a fusion of technologies that is blurring the lines between the physical, digital, and biological spheres.

With the help of technology (Internet of health, telepharmacy, apps, artificial intelligence, virtual assistants, wearables, digital therapeutics and blockchain between other technologies) many governments and payers have the ambition to prevent illness and transfer as much as possible hospital care to the community and home care, as most patients experience being ill at home as more convenient and recovering and much treatment patterns are less expensive once executed in a home situation.

This session explores the impact that this ambition has on pharmaceutical care and the enormous opportunities hammock healthcare offers to all regions globally.

 

Programme

  1. New entrants in pharmaceutical care: Focus on prevention
    Niels van Namen, CEVA Logistics, France
  2. Data to support digital triage improving access in rural Africa
    Raymond Muganga, Rwanda Pharmacy Council, Rwanda
  3. Artificial Intelligence to deliver integrated pharmaceutical care outcomes
    Michel van Beek, Swyft Healthcare, Netherlands
  4. Patient journeys, technology and continuity of care: The role of the oncology pharmacist
    Josep Guiu-Segura, FIP Hospital Pharmacy Section, Spain

Learning Objectives

At the end of this session, participants will be able to:

  1. Formulate how new personal digital data allow care to move from hospital to the home situations
  2. Describe how patient journeys will change and 24/7 care accessibility at the highest quality level will be possible
  3. Outline how to adopt technology and understand when to use it (and when not)
  4. Discuss how to take the patient perspective into (ethical) account when moving to hammock healthcare